serw-MX  [xml]  

 DeCS Categories

C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.035 Adenoma .
C04.557.470.035.100 Adenoma, Islet Cell .
C04.557.470.035.100.852 Insulinoma .
C04.588 Neoplasms by Site .
C04.588.274 Digestive System Neoplasms .
C04.588.274.761 Pancreatic Neoplasms .
C04.588.274.761.249 Adenoma, Islet Cell .
C04.588.274.761.249.500 Insulinoma .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.475 Pancreatic Neoplasms .
C04.588.322.475.249 Adenoma, Islet Cell .
C04.588.322.475.249.500 Insulinoma .
C06 Digestive System Diseases .
C06.301 Digestive System Neoplasms .
C06.301.761 Pancreatic Neoplasms .
C06.301.761.249 Adenoma, Islet Cell .
C06.301.761.249.500 Insulinoma .
C06.689 Pancreatic Diseases .
C06.689.667 Pancreatic Neoplasms .
C06.689.667.249 Adenoma, Islet Cell .
C06.689.667.249.500 Insulinoma .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.394 Glucose Metabolism Disorders .
C18.452.394.968 Hyperinsulinism .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.421 Pancreatic Neoplasms .
C19.344.421.249 Adenoma, Islet Cell .
C19.344.421.249.500 Insulinoma .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.699 Peptide Hormones .
D06.472.699.587 Pancreatic Hormones .
D06.472.699.587.200 Insulins .
D06.472.699.587.200.500 Proinsulin .
D06.472.699.587.200.500.625 Insulin .
D06.472.699.587.200.500.625.700 Insulin, Regular, Pork .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.480 Metalloendopeptidases .
D08.811.277.656.300.480.300 Insulysin .
D08.811.277.656.675 Metalloproteases .
D08.811.277.656.675.374 Metalloendopeptidases .
D08.811.277.656.675.374.300 Insulysin .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.548 Peptide Hormones .
D12.644.548.586 Pancreatic Hormones .
D12.644.548.586.200 Insulins .
D12.644.548.586.200.500 Proinsulin .
D12.644.548.586.200.500.625 Insulin .
D12.644.548.586.200.500.625.700 Insulin, Regular, Pork .
E02 Therapeutics .
E02.319 Drug Therapy .
E02.319.300 Drug Delivery Systems .
E02.319.300.508 Insulin Infusion Systems .
E07 Equipment and Supplies .
E07.505 Infusion Pumps .
E07.505.508 Insulin Infusion Systems .
E07.858 Surgical Equipment .
E07.858.082 Artificial Organs .
E07.858.082.505 Infusion Pumps .
E07.858.082.505.508 Insulin Infusion Systems .
HP4 Materia Medica .
HP4.018 Homeopathic Remedy .
HP4.018.375 Homeopathic Remedy I .
HP4.018.375.508 Insulinum .
VS2 Health Surveillance of Products .
VS2.006 Control and Sanitary Supervision of Equipment and Supplies .
VS2.006.002 Equipment and Supplies, Hospital .
VS2.006.002.013 Infusion Pumps .
VS2. Insulin Infusion Systems .
 Synonyms & Historicals
Insulin Infusion Systems .
Implantable Programmable Insulin Pump .
Insulin Pump, Programmable Implantable .
Pump, Programmable Implantable Insulin .
Artificial Endocrine Pancreas .
Artificial beta Cell .
Artificial beta Cells .
Cell, Artificial beta .
Cells, Artificial beta .
Endocrine Pancreas, Artificial .
Infusion System, Insulin .
Infusion Systems, Insulin .
Insulin Infusion System .
System, Insulin Infusion .
Systems, Insulin Infusion .
beta Cells, Artificial .
beta Cell, Artificial .
Pancreas, Artificial Endocrine .
Programmable Implantable Insulin Pump .
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. .
Insulin .
Iletin .
Insulin A Chain .
Insulin B Chain .
Insulin, Regular .
Novolin .
Sodium Insulin .
Soluble Insulin .
Chain, Insulin B .
Insulin, Sodium .
Insulin, Soluble .
Regular Insulin .
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). .
Insulins .
Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER, MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS. .
Insulysin .
Insulin Protease .
Insulin Proteinase .
Insulin-Degrading Enzyme .
Enzyme, Insulin-Degrading .
Insulin Degrading Enzyme .
Protease, Insulin .
Proteinase, Insulin .
Insulinase .
An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. (Eur J Biochem 1994;223:1-5) EC .
Insulinum .
Homeopathic remedy. Abbrev.: "ins.". Animal origin. Substance used: pancreas hormone. .
Insulinoma .
Adenoma, beta Cell .
Adenomas, beta-Cell .
Insulinomas .
Insulomas .
Tumor, beta-Cell .
Tumors, beta-Cell .
beta Cell Tumor .
beta-Cell Adenoma .
beta-Cell Adenomas .
beta-Cell Tumors .
Insuloma .
beta-Cell Tumor .
Adenoma, beta-Cell .
A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA. .
Hyperinsulinism .
Compensatory Hyperinsulinemia .
Endogenous Hyperinsulinism .
Exogenous Hyperinsulinism .
Hyperinsulinemia .
Hyperinsulinemia, Compensatory .
Hyperinsulinism, Endogenous .
Hyperinsulinism, Exogenous .
Hyperinsulinemia .
A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. .
Insulin, Regular, Pork .
Insulin, Regular, Porcine .
Porcine Insulin .
Velosulin .
Insulin, Porcine .
Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence. .